OrPha Swiss GmbH
- B01 - Agentes antitrombóticos
- TREPROSTINIL ORPHA solution for infusion 1 mg/ml
- TREPROSTINIL ORPHA solution for infusion 10 mg/ml
- TREPROSTINIL ORPHA solution for infusion 2.5 mg/ml
- TREPROSTINIL ORPHA solution for infusion 5 mg/ml
- B02 - Antihemorrágicos
- TRANEXAMIC ORPHA solution for injection 1 000 mg/10 ml
- TRANEXAMIC ORPHA solution for injection 500 mg/5 ml
- C02 - Antihipertensivos
- AMBRISENTAN ORPHA film-coated tablet 10 mg
- AMBRISENTAN ORPHA film-coated tablet 5 mg
- C07 - Betabloqueantes
- ESMOLOL ORPHA LYO concentrate for solution for infusion 2 500 mg/50 ml
- ESMOLOL ORPHA solution for injection 100 mg/10 ml
- RAPIBLOC powder for solution for infusion 300 mg
- G04 - Urológicos
- TADALAFIL PAH ORPHA film-coated tablet 20 mg
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- EMPRESSIN concentrate for solution for injection 40 IU/2 ml
- J01 - Antibacterianos para uso sistémico
- AMOXICILLIN ORPHA powder for solution for injection 1 g
- AMOXICILLIN ORPHA powder for solution for injection 2 g
- AMOXICILLIN ORPHA powder for solution for injection 250 mg
- AMOXICILLIN ORPHA powder for solution for injection 500 mg
- CEFEPIME ORPHA powder for solution for injection 1 g
- CEFEPIME ORPHA powder for solution for injection 2 g
- L01 - Antineoplásicos
- THROMBOREDUCTIN capsule, hard 0.5 mg
- THROMBOREDUCTIN capsule, hard 1 mg
- L03 - Inmunoestimulantes
- BESREMI PREFILLED PEN solution for injection 250 µg/0.5 ml
- BESREMI PREFILLED PEN solution for injection 500 µg/0.5 ml
- N02 - Analgésicos
- NALBUPHIN ORPHA solution for injection 20 mg/2 ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- NALTREXIN film-coated tablet 50 mg
- V03 - Todos los demás preparados terapéuticos
- NALOXON ORPHA solution for injection 0.4 mg/1 ml